<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Wrenn | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/antfoam76/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/antfoam76/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Wrenn.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">9a4c289b6f6e854a290ba730e2f13d52</guid>
				<title>Wrenn posted an update: Animal choruses, such as those found in insects and frogs, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41540/</link>
				<pubDate>Sat, 08 Feb 2025 09:27:05 -0800</pubDate>

									<content:encoded><![CDATA[<p>Animal choruses, such as those found in insects and frogs, are often intermittent. Thus, females sampling males in the chorus might have to remember the location of the potential mates&#8217; calls during periods of silence. Although a number of studies have shown that frogs use and prefer multimodal mating signals, usually acoustic plus visual, it is&hellip;<span class="activity-read-more" id="activity-read-more-41540"><a href="http://www.nationalboardinstitute.com/activity/p/41540/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">930d3fb5b6e01ccdea00f43026af7ae5</guid>
				<title>Wrenn posted an update: Conducting a medical exam in the COVID-19 era carries a [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36991/</link>
				<pubDate>Mon, 03 Feb 2025 08:37:37 -0800</pubDate>

									<content:encoded><![CDATA[<p>Conducting a medical exam in the COVID-19 era carries a great challenge for the institutions. Institutions should allow for some degree of flexibility when carrying out exams to prevent suffering of the candidates from the difficult circumstances.</p>
<p>Conducting a medical exam in the COVID-19 era carries a great challenge for the institutions.&hellip;<span class="activity-read-more" id="activity-read-more-36991"><a href="http://www.nationalboardinstitute.com/activity/p/36991/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5eeff00f724780c9906cf23e14062c94</guid>
				<title>Wrenn posted an update: These ex vivo results contradict previous in vitro and in [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36248/</link>
				<pubDate>Sun, 02 Feb 2025 09:14:51 -0800</pubDate>

									<content:encoded><![CDATA[<p>These ex vivo results contradict previous in vitro and in vivo reports of how MSC and their secretome may affect the microenvironment of the spinal cord after injury and highlight the importance of a careful comparison of the different experimental conditions used to assess the potential of cell therapies for the treatment of spinal cord&hellip;<span class="activity-read-more" id="activity-read-more-36248"><a href="http://www.nationalboardinstitute.com/activity/p/36248/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6a24cdee0ed1b67343fb45437b209a9d</guid>
				<title>Wrenn posted an update: Importantly, TS-121 showed a clearer efficacy for patients [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35336/</link>
				<pubDate>Sat, 01 Feb 2025 09:02:57 -0800</pubDate>

									<content:encoded><![CDATA[<p>Importantly, TS-121 showed a clearer efficacy for patients with higher basal cortisol levels than for those with lower basal cortisol levels, which was consistent with the hypothesis that V1B receptor antagonists may be more effective for patients with HPA axis hyperactivity. Therefore, V1B receptor antagonists are promising approaches for the&hellip;<span class="activity-read-more" id="activity-read-more-35336"><a href="http://www.nationalboardinstitute.com/activity/p/35336/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e77ff03192f520fa67b4cc1b4b828222</guid>
				<title>Wrenn posted an update: Heterogeneity by demographic factors in the respondents' [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33389/</link>
				<pubDate>Thu, 30 Jan 2025 09:06:38 -0800</pubDate>

									<content:encoded><![CDATA[<p>Heterogeneity by demographic factors in the respondents&#8217; willingness to accept a vaccine if recommended by employers were substantial when comparing responses from Brazil, Ecuador, France, India, Italy, Mexico, Poland, Russia, South Africa, South Korea, Sweden, and the US. This information should help public health authorities target vaccine&hellip;<span class="activity-read-more" id="activity-read-more-33389"><a href="http://www.nationalboardinstitute.com/activity/p/33389/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d28f269bc422e2329f1b5e108898d0a6</guid>
				<title>Wrenn posted an update: Maximizing the catalytic activity of single-atom catalysts [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32921/</link>
				<pubDate>Wed, 29 Jan 2025 09:08:39 -0800</pubDate>

									<content:encoded><![CDATA[<p>Maximizing the catalytic activity of single-atom catalysts is vital for the application of single-atom catalysts in industrial water-alkali electrolyzers, yet the modulation of the catalytic properties of single-atom catalysts remains challenging. Here, we construct strain-tunable sulphur vacancies around single-atom Ru sites for accelerating the&hellip;<span class="activity-read-more" id="activity-read-more-32921"><a href="http://www.nationalboardinstitute.com/activity/p/32921/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4c0d5aff32c1a058fe7bb31ccaebc1f5</guid>
				<title>Wrenn posted an update: 3), and responses were durable (12-month DoR rate, 63%, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/26730/</link>
				<pubDate>Tue, 28 Jan 2025 08:23:33 -0800</pubDate>

									<content:encoded><![CDATA[<p>3), and responses were durable (12-month DoR rate, 63%, median DoR 15.7 months). The 12-month PFS rate was 55% (median PFS 15.7 months), and the 12-month OS rate was 81% (median OS not estimable). In 24 patients with measurable baseline CNS metastases by blinded independent central review, the intracranial ORR was 79.2% (n = 19; 95% CI, 57.9 to&hellip;<span class="activity-read-more" id="activity-read-more-26730"><a href="http://www.nationalboardinstitute.com/activity/p/26730/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">20ca7c29392be4efd7e0f7994c22d0f1</guid>
				<title>Wrenn became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/26697/</link>
				<pubDate>Tue, 28 Jan 2025 08:20:57 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>